ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "matrix metalloproteinase (MMP) and rheumatoid arthritis (RA)"

  • Abstract Number: 990 • 2018 ACR/ARHP Annual Meeting

    Guanylate Binding Protein 5 (GBP5) Inhibits Rheumatoid Arthritis Synovial Fibroblast Mediated Inflammation and Tissue Destruction

    Mahamudul Haque1, Anil K. Singh1 and Salahuddin Ahmed1,2, 1Department of Pharmaceutical Sciences, Washington State University, College of Pharmacy, Spokane, WA, 2Division of Rheumatology, University of Washington, Division of Rheumatology, School of Medicine, Seattle, WA

    Background/Purpose: Guanylate binding protein 5 (GBP5), an interferon gamma (IFN-γ) inducible protein, helps to defend against invading pathogens. However, its role and properties beyond anti-viral…
  • Abstract Number: 1498 • 2018 ACR/ARHP Annual Meeting

    Serum MMP-3 More Than 155ng/Ml at Baseline Predicts One-Year Radiographic Progression in Patients with Rheumatoid Arthritis

    Jian-Da Ma1, Jun-Wei Wang2, Yan-Hui Xu2, Kui-Min Yang2, Le-Feng Chen2, Jian-Zi Lin2 and Lie Dai2, 1Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangdong, China, 2Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China

    Background/Purpose: Core disease activity indicators of rheumatoid arthritis (RA) have been found to be limited in predicting joint destruction progression. We previously reported that continuously…
  • Abstract Number: 1499 • 2018 ACR/ARHP Annual Meeting

    Elevated Serum MMP-3 in Remission Predicts Relapsed in Patients with Rheumatoid Arthritis

    Le-Feng Chen1, Jian-Da Ma2, Jun-Wei Wang1, Yan-Hui Xu1, Kui-Min Yang1, Jian-Zi Lin1 and Lie Dai1, 1Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China, 2Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangdong, China

    Background/Purpose: Our previous study showed continuously elevated serum matrix metalloproteinase (MMP)-3 predicted one-year radiographic progression (RP) in RA and the cutoff value at 6th month…
  • Abstract Number: 489 • 2017 ACR/ARHP Annual Meeting

    Endotypic Clustering of Rheumatoid Arthritis Patients through the Use of Tissue Specific Serum Biomarkers Identifies Structural Progressors

    Joseph Patrick Michele Blair1, Cecilie Liv Bager1, Line Mærsk Staunstrup1, Henning Bay Nielsen1, Morten Karsdal2 and Anne-C. Bay-Jensen3, 1ProScion, Herlev, Denmark, 2Biomarkers and Reseacrh, Nordic Bioscience, Herlev, Denmark, 3Biomarkers and Reseach, Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Treatment of RA patients is guided by measures of disease activity such as DAS28, best practice recommendation, and less often by a treat-to-target approach.…
  • Abstract Number: 963 • 2017 ACR/ARHP Annual Meeting

    Artesunate Inhabits Migration and Invasion of Fibroblast-like Synoviocytes and Matrix Metalloproteinases Expression Via Suppression of PI3K/Akt Pathway in Rheumatoid Arthritis

    Jian-Da Ma1, Jun Jing1, Tao Yan2, Ying-Qian Mo1 and Lie Dai1, 1Department of Rheumatology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China, 2Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China

    Background/Purpose: Fibroblast-like synoviocytes (FLS) play major roles on joint destruction in rheumatoid arthritis (RA) through migrating and invasing cartilage and bone by secreting proteases such…
  • Abstract Number: 2153 • 2016 ACR/ARHP Annual Meeting

    Syndecans Mediate Rantes/CCL5 Induced MMP-1 and MMP-13 Expression in Rheumatoid Arthritis Synovial Fibroblasts

    Solomon Agere, Nahid Akhtar and Salahuddin Ahmed, Department of Pharmaceutical Sciences, Washington State University, College of Pharmacy, Spokane, WA

    Background/Purpose:   RANTES/CCL5 (RANTES) is a C-C chemokine that binds to its receptor (CCR5) and initiates inflammatory processes in rheumatoid arthritis (RA) by facilitating leukocyte…
  • Abstract Number: 2565 • 2016 ACR/ARHP Annual Meeting

    Common Biomarker Elevations in Idiopathic Pulmonary Fibrosis and Rheumatoid Arthritis-Associated Interstitial Lung Disease

    Karen Fernandez1, Tracy Doyle2, Lisa Harlow3, Ivan O. Rosas4 and Dana P. Ascherman5, 1Rheumatology, University of Miami Miller School of Medicine, Miami, FL, 2Medicine/Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, 3Rheumatology and Clinical Immunology, University of Miami Miller School of Medicine, Miami, FL, 4BWH - Pulmonary, Brigham and Women's Hospital, Boston, MA, 5Medicine/Rheumatology, University of Miami Miller School of Medicine, Miami, FL

    Background/Purpose:  Interstitial lung disease (ILD) is an extra-articular manifestation of rheumatoid arthritis (RA) which contributes to increased morbidity and mortality. Clinico-epidemiological data indicate some overlap…
  • Abstract Number: 2577 • 2016 ACR/ARHP Annual Meeting

    Elevated Matrix Metalloproteinases Levels in Oral Fluids of Most Rheumatoid Arthritis Patients, Even without Frank Periodontitis

    Sheila Arvikar1, Hatice Hasturk2, Klemen Strle3, Marcy Bolster4, Deborah Collier5, Alpdogan Kantarci2 and Allen C. Steere6, 1Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Charlestown, MA, 2Department of Applied Oral Health Sciences, Forsyth, Cambridge, MA, 3Massachusetts General Hospital, Harvard Medical School, Boston, MA, 4Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 5Rheumatology, Massachusetts General Hospital, Boston, MA, 6Center for Immunolgy and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose:  Periodontitis shares pathogenic mechanisms with rheumatoid arthritis (RA) and may trigger its onset. However, little information is available about inflammatory responses in oral fluids…
  • Abstract Number: 583 • 2015 ACR/ARHP Annual Meeting

    A Serological Biomarker of Active MMP3, but Total MMP3, Can Early Assess Treatment Efficacy and Differentiate Doses of Tocilizumab and an Early Change in Active MMP3, but Not Total MMP3, Is Associated with Radiographic Change at 1 Year

    Anne Sofie Siebuhr1, Stephanie Nina Kehlet2, Kishwar Musa2, Inger Byrjalsen3, Morten Asser Karsdal4 and Anne C. Bay-Jensen5, 1Rheumatology, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 2Laboratory, Nordic Bioscience, Herlev, Denmark, 3Research & Development, Nordic Bioscience, Herlev, Denmark, 4Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 5Biomarkers and Research, Rheumatology, Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Protease activity, especially MMP3, is known to be increased with arthritis, such as rheumatoid arthritis. MMP3 is mainly expressed by fibroblasts; a key cell…
  • Abstract Number: 1101 • 2015 ACR/ARHP Annual Meeting

    Matrix Metalloproteinase-10 (Stromelysin 2) Is a Target of Robust Autoimmune T and B Cell Responses in Antibiotic-Refractory Lyme Arthritis, but Not in Rheumatoid Arthritis

    Jameson T. Crowley1, Elise E. Drouin2, Annalisa Pianta1, Klemen Strle1, Qi Wang3, Catherine E. Costello3 and Allen C. Steere4, 1Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 2Medicine, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 3Center for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, MA, 4Center for Immunolgy and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: Infection-induced autoimmunity has been hypothesized to have a pathogenic role in antibiotic-refractory Lyme arthritis (LA). We previously identified 3 autoantigens, endothelial cell growth factor,…
  • Abstract Number: 2429 • 2014 ACR/ARHP Annual Meeting

    Seasonal Changes May Influence Activity of Rheumatoid Arthritis

    Ryuji Nagamine, Bone and Joint Center, Sugioka Memorial Hospital, Fukuoka, Japan

    Background/Purpose: RA activity during the year was assessed to investigate whether seasonal changes influenced parameters of RA activity. Methods: This study was performed in Fukuoka,…
  • Abstract Number: 1653 • 2013 ACR/ARHP Annual Meeting

    Rheumatoid Arthritis Synovial IL-21+CD4+ T Cells Specifically Induce Matrix Metalloproteinase Production By Fibroblast-Like Synoviocytes

    Maria C. Lebre1, Pedro L. Vieira2, Saïda Aarrass1, Thomas Newsom-Davis2, Paul Peter Tak3 and Gavin R. Screaton2, 1Clinical Immunology and Rheumatology & Experimental Immunology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 2Department of Immunology, Imperial College London, London, United Kingdom, 3Academic Medical Center / University of Amsterdam, Department of Clinical Immunology and Rheumatology & GlaxoSmithKline, Amsterdam, Netherlands

    Background/Purpose: IL-21 is a cytokine produced by activated CD4+ T cells and T follicular helper cells (TFh) that has been implicated in several autoimmune diseases…
  • Abstract Number: 1349 • 2013 ACR/ARHP Annual Meeting

    High Rate Of Improvement In Serum Matrix Metalloproteinase-3 Levels At 4 Weeks Predict Remission At 52 Weeks In RA Patients With Adalimumab Therapy

    Yosuke Hattori1, Atsushi Kaneko1, Daihei Kida2, Hisato Ishikawa3, Toshihisa Kojima4 and Naoki Ishiguro5, 1Orthopedic Surgery and Rheumatology, Nagoya Medical Center, Nagoya, Japan, 2Department of Rheumatology and Orthopedic Surgery, Nagoya Medical Center, Nagoya, Japan, 3Nagoya Medical Center, nagano, Japan, 4Orthopedic Surgery and Rheumatology, Nagoya University Hospital, Nagoya, Japan, 5Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Background/Purpose : Serum MMP-3 is a specific inflammatory marker of the synovium in patients with rheumatoid arthritis (RA). Our aim in this study is to…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology